RecensMedical, Inc. (KOSDAQ:394420)

South Korea · Delayed Price · Currency is KRW

6,710.00

+110.00 (1.67%)

At close: Oct 21, 2026

Market Cap	73.81B
Revenue (ttm)	6.52B +4.2%
Net Income	-11.05B
EPS	-1,126.22
Shares Out	11.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	41,035
Open	6,930.00
Previous Close	6,600.00
Day's Range	6,570.00 - 6,930.00
52-Week Range	5,970.00 - 39,900.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About RecensMedical

RecensMedical, Inc. operates as a medical device company specializing in precision cooling therapy and transdermal drug delivery solutions. The company engages in the development of precision medical cooling device in the fields of ophthalmology and dermatology. The company’s products include OcuCool, a hand-held, cooling anesthesia device that provides rapid and controlled cooling to the conjunctiva and sclera, and TargetCool, a handheld device that delivers rapid, precise, and controlled cooling to the skin tissue for the temporary reduction ... [Read more]

Industry Surgical and Medical Instruments and Apparatus

Founded 2016

Employees 50

Stock Exchange KOSDAQ

Ticker Symbol 394420

Full Company Profile

Financial Performance

In 2025, RecensMedical's revenue was 8.83 billion, an increase of 41.05% compared to the previous year's 6.26 billion. Losses were -19.12 billion, 143.8% more than in 2024.

Financial Statements